339 related articles for article (PubMed ID: 21317894)
1. Structural basis for engagement by complement factor H of C3b on a self surface.
Morgan HP; Schmidt CQ; Guariento M; Blaum BS; Gillespie D; Herbert AP; Kavanagh D; Mertens HD; Svergun DI; Johansson CM; Uhrín D; Barlow PN; Hannan JP
Nat Struct Mol Biol; 2011 Apr; 18(4):463-70. PubMed ID: 21317894
[TBL] [Abstract][Full Text] [Related]
2. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
[TBL] [Abstract][Full Text] [Related]
3. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
4. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional characterization of the product of disease-related factor H gene conversion.
Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
[TBL] [Abstract][Full Text] [Related]
6. Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus).
Pechtl IC; Neely RK; Dryden DT; Jones AC; Barlow PN
Protein Sci; 2011 Dec; 20(12):2102-12. PubMed ID: 21936007
[TBL] [Abstract][Full Text] [Related]
7. Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
Osborne AJ; Nan R; Miller A; Bhatt JS; Gor J; Perkins SJ
J Biol Chem; 2018 Nov; 293(44):17166-17187. PubMed ID: 30217822
[TBL] [Abstract][Full Text] [Related]
8. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses.
Xue X; Wu J; Ricklin D; Forneris F; Di Crescenzio P; Schmidt CQ; Granneman J; Sharp TH; Lambris JD; Gros P
Nat Struct Mol Biol; 2017 Aug; 24(8):643-651. PubMed ID: 28671664
[TBL] [Abstract][Full Text] [Related]
9. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
Kajander T; Lehtinen MJ; Hyvärinen S; Bhattacharjee A; Leung E; Isenman DE; Meri S; Goldman A; Jokiranta TS
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2897-902. PubMed ID: 21285368
[TBL] [Abstract][Full Text] [Related]
10. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
12. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
[TBL] [Abstract][Full Text] [Related]
13. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
[TBL] [Abstract][Full Text] [Related]
14. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
15. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
Li K; Gor J; Holers VM; Storek MJ; Perkins SJ
J Mol Biol; 2012 May; 418(3-4):248-63. PubMed ID: 22387467
[TBL] [Abstract][Full Text] [Related]
17. Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations.
Hocking HG; Herbert AP; Kavanagh D; Soares DC; Ferreira VP; Pangburn MK; Uhrín D; Barlow PN
J Biol Chem; 2008 Apr; 283(14):9475-87. PubMed ID: 18252712
[TBL] [Abstract][Full Text] [Related]
18. A new map of glycosaminoglycan and C3b binding sites on factor H.
Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
[TBL] [Abstract][Full Text] [Related]
19. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.
Pechtl IC; Kavanagh D; McIntosh N; Harris CL; Barlow PN
J Biol Chem; 2011 Apr; 286(13):11082-90. PubMed ID: 21270465
[TBL] [Abstract][Full Text] [Related]
20. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
Jokiranta TS; Jaakola VP; Lehtinen MJ; Pärepalo M; Meri S; Goldman A
EMBO J; 2006 Apr; 25(8):1784-94. PubMed ID: 16601698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]